Loading viewer...
investor_presentation
Format: PDF investor_presentation
Krka, a leading global generic pharmaceutical company, presents 2023 financial results and 2024 business guidance. The company operates across 70+ markets through 6 sales regions, manufacturing locations worldwide, and serves 55+ million daily patients with affordable medicines.
investor_presentation
23 Pages
Agora
Chia Hsin Cement 2024 Q2 Investor Presentation
investor_presentationinvestor_presentation
15 Pages
Chia Hsin Cement Corporation